InterAct Therapeutics, Inc. — Form D

InterAct Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-21. The offering totals $2.0M, of which $250K was reported sold. Industry: Other Health Care.

Offering

• Filed: 2026-07-21
• Form: D
• Accession: 0002107143-26-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $250K
• Remaining: $1.8M
• Investors: 1
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-591571

Issuer

• Name: InterAct Therapeutics, Inc.
• CIK: 0002107143
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 3060 PEGASUS PARK DRIVE BUILDING 6, DALLAS, TX, 75247
• Phone: 2107102867

Officers, directors & promoters (2)

More

• CIK 2107143 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search